View Email in Browser External Web Site Policy

Rehabilitation Research News: July 25, 2022

From the Director's Desk

Because of the Fourth of July holiday, I missed the last issue, so this newsletter is jam-packed. Here are the top things to know:


Elements of Style in Reproducible Workflow Creation and Analysis: A Kids First Training Event

August 22 to 26, 2022
11 a.m. to 1 p.m. ET each day

The Gabriella Miller Kids First Pediatric Research Program (Kids First) is an NIH Common Fund program focusing on the biology of childhood cancer and structural birth defects. The program created the Gabriella Miller Kids First Data Resource External Web Site Policy. This cloud-based platform publicly shares genetic and clinical data from childhood cancer and structural birth defect cohorts. It includes the Gabriella Miller Kids First Data Resource Portal External Web Site Policy and other tools to foster analysis and collaboration.

Join NIH Data and Technology Advancement (DATA) Scholar Anne Deslattes Mays, Ph.D., August 22 to 26 for 2 hours each day as she hosts this weeklong Kids First Data Resource training event and learn how to use and share reproducible analysis workflows in analyzing genomics and other “-omics” datasets in the cloud.

  • Over the course of five scheduled 2-hour sessions, users will learn:
    • Reasoning with Jupyter Lab Notebooks (Python or R kernels)
    • Code versioning with Git and GitHub
    • Containerization with Conda and Docker
    • Workflow development and execution

This class will use Seven Bridges' CAVATICA External Web Site Policy platform to conduct cloud-based analyses.

* Requirements include a web browser (Chrome preferred, registration through the Kids First Data Resource Center) and Internet access.

Space is limited for this event, so we suggest that you register External Web Site Policy early. Email if you have any questions.

Notices and Funding Opportunities

NIH Notices and Funding Opportunities

NIDA, NIMH, and NINDS Research Opportunities for New and “At-Risk” Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)

This FOA solicits R01 grant applications from “new investigators” and “at-risk investigators” from diverse backgrounds, including those from groups underrepresented in the health-related sciences (e.g., see NOT-OD-20-031, Notice of NIH’s Interest in Diversity), in order to enhance the diversity of R01-funded investigators. 

Only applications that fall within the scientific missions of the National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), or National Institute of Neurological Disorders and Stroke (NINDS) will be considered for funding.

  • Program Announcement
  • Due Dates for New Applications
    • September 8, 2022; January 6, 2023; May 5, 2023; September 6, 2023; January 9, 2024; May 6, 2024; September 6, 2024; January 8, 2025; May 5, 2025
  • Due Dates for Resubmission Applications
    • October 6, 2022; February 7, 2023; June 6, 2023; October 6, 2023; February 6, 2024; June 6, 2024; October 8, 2024; February 6, 2025; June 6, 2025
  • Funds Available
    • NINDS intends to commit up to $10 million per fiscal year, approximately 25 awards, dependent on award amounts.
    • NIDA intends to commit up to $5 million per fiscal year, 12 to 15 awards, dependent on award amounts.
    • NIMH intends to commit up to $5 million per fiscal year, 12 to 15 awards, dependent on award amounts.
  • Definitions
    • New investigator: A new investigator (NI) has had no previous NIH support as a principal investigator (PI) on a substantial independent research award. This includes early stage investigators (ESIs).
    • At-risk investigator: An at-risk investigator has had previous support as a PI on a substantial independent research award and will have no substantial research grant funding in the following fiscal year unless successful in securing a substantial research grant award in the current fiscal year.
    • Substantial independent research award: A substantial independent research award is any NIH research grant award, excluding smaller grants that maintain the recipient’s ESI and new investigator (NI) status. See the list of awards that an investigator can receive while still maintaining ESI/NI status.
  • Required Component
    • Institutional Eligibility Letter is required for all applicants. The Institutional Eligibility Letter certifies that the program director (PD)/PI satisfies the eligibility criteria listed in the FOA under Section III, “Eligible Individuals (Program Director/Principal Investigator).” It must also include a statement explaining how the participation of the identified PD(s)/PI(s) would further the goals of the new and at-risk investigators to promote the Research Workforce Diversity Program, consistent with the Notice of NIH’s Interest in Diversity (NOT-OD-20-031). The Institutional Eligibility Letter must be signed by an institutional official and uploaded under Other Attachments. Applications missing an Institutional Eligibility Letter will be deemed incomplete and withdrawn.

Please visit the NINDS website to see Frequently Asked Questions.

NICHD Home / NCMRR Home / Subscribe External Web Site Policy / Unsubscribe External Web Site Policy

Rehabilitation Research News is delivered bi-monthly to subscribers.

Our mailing address is:

Eunice Kennedy Shriver National Institute of Child Health and Human Development
31 Center Drive
Building 31
Bethesda, MD 20892-2425

HHS, NIH, and NICHD logos